- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Gout, flares, and allopurinol use: a population-based study ; volume:21 ; number:1 ; day:31 ; month:5 ; year:2019 ; pages:1-8 ; date:12.2019
Arthritis Research & Therapy ; 21, Heft 1 (31.5.2019), 1-8, 12.2019
- Urheber
-
Proudman, Charlotte
Lester, Susan E.
Gonzalez-Chica, David A.
Gill, Tiffany K.
Dalbeth, Nicola
Hill, Catherine L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-019-1918-7
- URN
-
urn:nbn:de:101:1-2019112719360321309224
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Proudman, Charlotte
- Lester, Susan E.
- Gonzalez-Chica, David A.
- Gill, Tiffany K.
- Dalbeth, Nicola
- Hill, Catherine L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Allopurinol and prostate cancer survival in a Finnish population-based cohort
Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
Cohort study investigating gout flares and management in UK general practice
ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
African American patients with gout: efficacy and safety of febuxostat vs allopurinol
Physical activity measured using wearable activity tracking devices associated with gout flares
Optimizing pulsatile release of febuxostat for managing gout flares: a chronotherapeutic approach
Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
The challenges of gout flare reporting: mapping flares during a randomized controlled trial
Patient and clinical characteristics associated with gout flares in an integrated healthcare system
Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
Allopurinol and prostate cancer survival in a Finnish population-based cohort
Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
Cohort study investigating gout flares and management in UK general practice
ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
African American patients with gout: efficacy and safety of febuxostat vs allopurinol
Physical activity measured using wearable activity tracking devices associated with gout flares
Optimizing pulsatile release of febuxostat for managing gout flares: a chronotherapeutic approach
Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
The challenges of gout flare reporting: mapping flares during a randomized controlled trial
Patient and clinical characteristics associated with gout flares in an integrated healthcare system
Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
Allopurinol and prostate cancer survival in a Finnish population-based cohort
Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
Cohort study investigating gout flares and management in UK general practice
ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
African American patients with gout: efficacy and safety of febuxostat vs allopurinol
Physical activity measured using wearable activity tracking devices associated with gout flares
Optimizing pulsatile release of febuxostat for managing gout flares: a chronotherapeutic approach
Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
The challenges of gout flare reporting: mapping flares during a randomized controlled trial
Patient and clinical characteristics associated with gout flares in an integrated healthcare system